Seblewongel Asrat

1.0k total citations · 1 hit paper
19 papers, 679 citations indexed

About

Seblewongel Asrat is a scholar working on Immunology, Physiology and Surgery. According to data from OpenAlex, Seblewongel Asrat has authored 19 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Physiology and 5 papers in Surgery. Recurrent topics in Seblewongel Asrat's work include IL-33, ST2, and ILC Pathways (8 papers), Asthma and respiratory diseases (7 papers) and Eosinophilic Esophagitis (5 papers). Seblewongel Asrat is often cited by papers focused on IL-33, ST2, and ILC Pathways (8 papers), Asthma and respiratory diseases (7 papers) and Eosinophilic Esophagitis (5 papers). Seblewongel Asrat collaborates with scholars based in United States and France. Seblewongel Asrat's co-authors include Ralph R. Isberg, Jamie Orengo, Andrew Murphy, Matthew A. Sleeman, George Scott, Audrey Le Floc’h, Wei Keat Lim, Kirsten Nagashima, Jeanne Allinne and Dylan Birchard and has published in prestigious journals such as Diabetes, Journal of Allergy and Clinical Immunology and Infection and Immunity.

In The Last Decade

Seblewongel Asrat

17 papers receiving 668 citations

Hit Papers

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seblewongel Asrat United States 7 274 237 197 121 116 19 679
Takashi Shikina Japan 10 134 0.5× 365 1.5× 112 0.6× 22 0.2× 18 0.2× 25 742
Thomas W. Spahn Germany 15 92 0.3× 566 2.4× 78 0.4× 42 0.3× 24 0.2× 24 907
Kanako Yoshida Japan 13 133 0.5× 70 0.3× 143 0.7× 34 0.3× 13 0.1× 31 479
Kristina Röschmann Netherlands 10 143 0.5× 264 1.1× 108 0.5× 12 0.1× 38 0.3× 13 510
Sudarshan Seshadri United States 11 163 0.6× 237 1.0× 167 0.8× 12 0.1× 9 0.1× 18 622
Svetlana Sergejeva Estonia 11 388 1.4× 197 0.8× 193 1.0× 5 0.0× 49 0.4× 14 735
Laurent Mascarell France 15 360 1.3× 261 1.1× 414 2.1× 8 0.1× 176 1.5× 24 779
Julie Joseph United States 9 161 0.6× 401 1.7× 161 0.8× 10 0.1× 26 0.2× 12 716
Patricia R. Taylor United States 14 83 0.3× 422 1.8× 25 0.1× 17 0.1× 42 0.4× 21 890
Catherine Sabatel Belgium 8 169 0.6× 730 3.1× 50 0.3× 12 0.1× 23 0.2× 12 957

Countries citing papers authored by Seblewongel Asrat

Since Specialization
Citations

This map shows the geographic impact of Seblewongel Asrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seblewongel Asrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seblewongel Asrat more than expected).

Fields of papers citing papers by Seblewongel Asrat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seblewongel Asrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seblewongel Asrat. The network helps show where Seblewongel Asrat may publish in the future.

Co-authorship network of co-authors of Seblewongel Asrat

This figure shows the co-authorship network connecting the top 25 collaborators of Seblewongel Asrat. A scholar is included among the top collaborators of Seblewongel Asrat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seblewongel Asrat. Seblewongel Asrat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jha, Mithilesh Kumar, Jeremy Huang, Yingnan Han, et al.. (2024). The IL‐4–IL4Rα axis modulates olfactory neuroimmune signaling to induce loss of smell. Allergy. 80(2). 440–461. 3 indexed citations
2.
Devlin, Joseph C., E. Condé, Gurinder S. Atwal, et al.. (2024). IgE plasma cells are transcriptionally and functionally distinct from other isotypes. Science Immunology. 9(99). eadm8964–eadm8964. 6 indexed citations
3.
Srivatsan, Subhashini, Seblewongel Asrat, Kirsten Nagashima, et al.. (2023). Interleukin-33 (IL-33) Drives Type 1 and Type 2 Inflammation and Instructs Airway Remodeling. A4473–A4473.
4.
Asrat, Seblewongel, Kirsten Nagashima, G. Richard Scott, et al.. (2023). IL-33 Initiates and Amplifies Both Type 1 and Type 2 Inflammation. Journal of Allergy and Clinical Immunology. 151(2). AB126–AB126. 1 indexed citations
5.
Asrat, Seblewongel, Joseph C. Devlin, Andrea Vecchione, et al.. (2023). TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells. Cell Reports Methods. 3(7). 100522–100522. 7 indexed citations
7.
Asrat, Seblewongel, et al.. (2022). 5′ Untranslated mRNA Regions Allow Bypass of Host Cell Translation Inhibition by Legionella pneumophila. Infection and Immunity. 90(11). 13–e0017922. 3 indexed citations
8.
Scott, George, Seblewongel Asrat, Jeanne Allinne, et al.. (2022). IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline. Cytokine. 162. 156091–156091. 54 indexed citations
9.
Asrat, Seblewongel, et al.. (2022). IL-33 and IL-4Rα blockade impact distinct and overlapping inflammatory mediators of airway disease. 477–477. 1 indexed citations
10.
Asrat, Seblewongel, Xia Liu, Li‐Hong Ben, et al.. (2020). Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory. Science Immunology. 5(43). 60 indexed citations
11.
Nagashima, Kirsten, George Scott, Dylan Birchard, et al.. (2020). Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation. Journal of Allergy and Clinical Immunology. 145(2). AB158–AB158. 5 indexed citations
12.
Floc’h, Audrey Le, Jeanne Allinne, Kirsten Nagashima, et al.. (2019). Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation. Allergy. 75(5). 1188–1204. 330 indexed citations breakdown →
13.
Allinne, Jeanne, George Scott, Dylan Birchard, et al.. (2019). Broader Impact of IL-4Ra Blockade Than IL-5 Blockade on Type 2 Inflammation. PA3877–PA3877. 2 indexed citations
14.
15.
Floc’h, Audrey Le, Jeanne Allinne, Kirsten Nagashima, et al.. (2019). Il-4 and IL-13 act independently and synergistically to drive type 2 inflammation. PA5206–PA5206. 1 indexed citations
16.
Asrat, Seblewongel, Kimberly M. Davis, & Ralph R. Isberg. (2015). Modulation of the host innate immune and inflammatory response by translocated bacterial proteins. Cellular Microbiology. 17(6). 785–795. 41 indexed citations
17.
Asrat, Seblewongel, Aisling S. Dugan, & Ralph R. Isberg. (2014). The Frustrated Host Response to Legionella pneumophila Is Bypassed by MyD88-Dependent Translation of Pro-inflammatory Cytokines. PLoS Pathogens. 10(7). e1004229–e1004229. 50 indexed citations
18.
Asrat, Seblewongel, et al.. (2014). Bacterial Pathogen Manipulation of Host Membrane Trafficking. Annual Review of Cell and Developmental Biology. 30(1). 79–109. 105 indexed citations
19.
Driver, John P., Yi‐Guang Chen, Weidong Zhang, Seblewongel Asrat, & David Serreze. (2011). Unmasking Genes in a Type 1 Diabetes–Resistant Mouse Strain That Enhances Pathogenic CD8 T-Cell Responses. Diabetes. 60(4). 1354–1359. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026